Press releases
- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis
- NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on Ketamine Efficacy and Risks at Upcoming Sachs Neuroscience Innovation Forum in San Francisco
- NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS Standard
Key statistics
As of last trade, NRX Pharmaceuticals Inc (B1QB:DEU) traded at 0.50, 201.20% above the 52 week low of 0.166 set on Sep 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.50 |
---|---|
High | 0.50 |
Low | 0.464 |
Bid | 0.494 |
Offer | 0.51 |
Previous close | 0.494 |
Average volume | 5.45k |
---|---|
Shares outstanding | 92.43m |
Free float | 63.67m |
P/E (TTM) | -- |
Market cap | 48.99m USD |
EPS (TTM) | -0.5107 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 09:50 BST.
More ▼